Header Emsos

EMSOS studies published

2021 – Cuomo P et al. Extra-abdominal desmoid tumor fibromatosis: a multicenter EMSOS study. BMC Cancer. 2021 Apr 20;21(1):437. doi: 10.1186/s12885-021-08189-6. PMID: 33879110; PMCID: PMC8059004.

2020 – Goedhart LM et al. Organization of Bone Sarcoma Care: A Cross-Sectional European Study. Orthop Surg. 2020;12(4):1030-1035. doi:10.1111/os.12716

2020 – Thaler M et al. Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours. Int Orthop. 2020 Aug;44(8):1503-1509. doi: 10.1007/s00264-020-04636-4. Epub 2020 May 26. PMID: 32451657; PMCID: PMC7247966.

2020 – Staals EL et al. Expandable distal femur megaprosthesis: A European Musculoskeletal Oncology Society study on 299 cases. J Surg Oncol. 2020 Jun 7. doi: 10.1002/jso.26060. Epub ahead of print. PMID: 32506533.

2020 – Schutgens EM et al. Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases. J Bone Joint Surg Am. 2020 Oct 7;102(19):1703-1713. doi: 10.2106/JBJS.19.01056. PMID: 33027124; PMCID: PMC8569856.

2019 – Mastboom MJL et al. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers. J Bone Joint Surg Am. 2019 Jul 17;101(14):1309-1318. doi: 10.2106/JBJS.18.01147. Erratum in: J Bone Joint Surg Am. 2020 May 20;102(10):e49. PMID: 31318811.

2019 – Mastboom MJL et al. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study. Lancet Oncol. 2019 Jun;20(6):877-886. doi: 10.1016/S1470-2045(19)30100-7. Epub 2019 Apr 24. PMID: 31029509.

2019 – Majoor BCJ et al. Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European Study. J Bone Joint Surg Am. 2019 Jan 16;101(2):160-168. doi: 10.2106/JBJS.18.00062. PMID: 30653046.

2017 – Longhi A et al. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. Eur J Cancer. 2017 Mar;74:9-16. doi: 10.1016/j.ejca.2016.12.016. Epub 2017 Feb 3. PMID: 28167373.

2015 – Frezza AM et al. Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer. 2015 Feb;51(3):374-81. doi: 10.1016/j.ejca.2014.11.007. Epub 2014 Dec 16. PMID: 25529371.

2015 – Verdegaal SH et al. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771-9. doi: 10.1634/theoncologist.2011-0200. Epub 2011 Dec 6. PMID: 22147000; PMCID: PMC3248776.

2011 – Pansuriya TC et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011 Nov 6;43(12):1256-61. doi: 10.1038/ng.1004. PMID: 22057234; PMCID: PMC3427908.

2007 – Grimer RJ et al. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer. 2007 Sep;43(14):2060-5. doi: 10.1016/j.ejca.2007.06.016. Epub 2007 Aug 27. PMID: 17720491.

2005 – Grimer RJ et al. Periosteal osteosarcoma–a European review of outcome. Eur J Cancer. 2005 Dec;41(18):2806-11. doi: 10.1016/j.ejca.2005.04.052. Epub 2005 Nov 14. PMID: 16290134.

2003 – Grimer RJ et al. Osteosarcoma over the age of forty. Eur J Cancer. 2003 Jan;39(2):157-63. doi: 10.1016/s0959-8049(02)00478-1. PMID: 12509946.

1999 – Bielack SS et al. Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand. 1999 Aug;70(4):353-60. doi: 10.3109/17453679908997824. PMID: 10569265.